Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A specific RNA can help hair growth in baldness by boosting stem cell activity.

Lithocholic acid helps hair growth and regeneration in alopecia by activating vitamin D receptors.

JAK inhibitors may help treat alopecia areata and promote hair regrowth.

Blocking JAK-STAT signaling can lead to hair growth.

JAK inhibitors show promise for treating skin disorders like alopecia, eczema, and psoriasis.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

Oral JAK inhibitors effectively treat alopecia areata and are generally well-tolerated.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

Blocking SCD1 in the skin with XEN103 shrinks sebaceous glands in mice.

Tofacitinib is more effective than traditional treatments for severe alopecia areata in children.

DHT inhibition may increase spinal bone growth in ankylosing spondylitis.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

A gene called APCDD1, which controls hair growth, is found to be faulty in a type of hair loss called hereditary hypotrichosis simplex.

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Cyproterone acetate at 2mg daily is as effective as higher doses for treating excessive hair growth in women.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

The HDDPiW-jSB solution may prevent hair loss caused by docetaxel in rats when applied regularly.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.

LDE225 is a promising skin-applied treatment for basal cell carcinoma with good skin penetration and effectiveness.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.

Janus kinase inhibitors can regrow hair in alopecia areata but may cause side effects and hair loss may return if treatment stops.

Early treatment with JAK inhibitors leads to better hair regrowth in acute alopecia areata.